Victrex plc (LON:VCT) Insider Martin Court Purchases 9 Shares

Victrex plc (LON:VCTGet Rating) insider Martin Court purchased 9 shares of the company’s stock in a transaction that occurred on Friday, September 16th. The shares were acquired at an average cost of GBX 1,684 ($20.35) per share, for a total transaction of £151.56 ($183.13).

Martin Court also recently made the following trade(s):

  • On Tuesday, August 16th, Martin Court purchased 8 shares of Victrex stock. The shares were acquired at an average cost of GBX 1,835 ($22.17) per share, for a total transaction of £146.80 ($177.38).

Victrex Stock Performance

VCT opened at GBX 1,661 ($20.07) on Wednesday. The company has a market cap of £1.44 billion and a PE ratio of 2,050.62. The stock has a 50-day moving average of GBX 1,814.12 and a 200-day moving average of GBX 1,789.70. Victrex plc has a 52-week low of GBX 1,585 ($19.15) and a 52-week high of GBX 2,580 ($31.17). The company has a debt-to-equity ratio of 5.23, a quick ratio of 1.99 and a current ratio of 3.42.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on VCT. Barclays upped their target price on Victrex from GBX 2,140 ($25.86) to GBX 2,190 ($26.46) and gave the stock an “overweight” rating in a research report on Wednesday, July 13th. Berenberg Bank reaffirmed a “hold” rating and issued a GBX 2,000 ($24.17) target price on shares of Victrex in a research report on Thursday, July 14th.

Victrex Company Profile

(Get Rating)

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities.

Read More

Insider Buying and Selling by Quarter for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with's FREE daily email newsletter.